Isolation of CD45RO+, memory T cells recognizing proteolipid protein from neurologically normal subjects

J B Burns1, B D Bartholomew, S T Lobo

  • 1Department of Neurology, Neurovirology Research 151B, V.A. Medical Center, University of Utah, 500 Foothill Drive, Salt Lake City, UT 84148, USA.

Cellular Immunology
|November 22, 2001
PubMed

Insights

In healthy individuals, about half of proteolipid protein-reactive T cells are memory cells, indicating prior in vivo activation. This suggests immune regulation may prevent disease despite T cell activation.

Area of Science:

  • Neuroimmunology
  • T cell immunology

Background:

  • Studies show in vivo activation of myelin basic protein (MBP)-reactive T cells in multiple sclerosis (MS).
  • In vivo T cell activation is generally less frequent in healthy controls.

Purpose of the Study:

  • To investigate the T cell response to proteolipid protein (PLP) in peripheral blood mononuclear cells (PBMCs) from healthy control subjects.
  • To assess in vivo activation of CD4+ T cells reactive with PLP using CD45 isotypes as memory and naive T cell markers.

Main Methods:

  • Isolation of PBMCs from 9 healthy control subjects.
  • Flow cytometry analysis using CD45 isotypes (e.g., CD45RO) to differentiate memory and naive T cells.
  • Assessment of T cell reactivity to PLP.

Main Results:

  • Approximately 50% of PLP-reactive T cells were identified within the CD45RO+ memory T cell subpopulation.
  • This contrasts with findings for MBP-reactive T cells in previous studies.
  • Indicates in vivo activation of PLP-reactive T cells in neurologically intact individuals.

Conclusions:

  • Myelin-reactive T cells, specifically PLP-reactive ones, are activated in vivo even in healthy individuals.
  • The presence of activated T cells suggests that immunoregulatory mechanisms may be active.
  • These mechanisms might prevent the development of overt neurological disease despite T cell activation.

Related Concept Videos